ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
65 hedge funds and large institutions have $78.1M invested in Zynerba Pharmaceuticals, Inc in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
-1
Holders Change %
-1.52%
% of All Funds
1.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
24
Reduced
16
Closed
12
Calls
$4.21M
Puts
$2.11M
Net Calls
+$2.1M
Net Calls Change
+$101K
Top Buyers
| 1 |
EMG
ETF Managers Group
Summit,
New Jersey
|
$24.8M |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
$8.67M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$9.92M |
| 4 |
D.E. Shaw & Co
New York
|
$5.68M |
| 5 |
Millennium Management
New York
|
$2.06M |
Top Sellers
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
$1.45M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$442K |
| 3 |
Squarepoint
New York
|
$0 |
| 4 |
Goldman Sachs
New York
|
$290K |
| 5 |
Two Sigma Advisers
New York
|
$680K |
